

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of T-helper 1 cell differentiation (GO:0045625) | 9.55026969 |
| 2 | positive regulation of antigen processing and presentation (GO:0002579) | 9.02355561 |
| 3 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 8.43230414 |
| 4 | regulation of antigen processing and presentation (GO:0002577) | 7.53319047 |
| 5 | positive regulation of receptor biosynthetic process (GO:0010870) | 7.40118639 |
| 6 | positive regulation of granulocyte chemotaxis (GO:0071624) | 7.29604928 |
| 7 | positive regulation of T-helper 1 type immune response (GO:0002827) | 6.83956468 |
| 8 | complement activation, classical pathway (GO:0006958) | 6.72199233 |
| 9 | regulation of lipoprotein particle clearance (GO:0010984) | 6.70456492 |
| 10 | positive regulation of T-helper cell differentiation (GO:0045624) | 6.29008420 |
| 11 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 6.26190576 |
| 12 | response to nitric oxide (GO:0071731) | 6.13541508 |
| 13 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 6.09779898 |
| 14 | positive regulation of neutrophil chemotaxis (GO:0090023) | 6.00114576 |
| 15 | positive regulation of neutrophil migration (GO:1902624) | 6.00114576 |
| 16 | peptide catabolic process (GO:0043171) | 5.93413744 |
| 17 | complement activation (GO:0006956) | 5.75609527 |
| 18 | NIK/NF-kappaB signaling (GO:0038061) | 5.68808603 |
| 19 | negative regulation of interleukin-10 production (GO:0032693) | 5.60174567 |
| 20 | response to prostaglandin E (GO:0034695) | 5.56232135 |
| 21 | oxygen transport (GO:0015671) | 5.51550827 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.39673582 |
| 23 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 5.25647950 |
| 24 | regulation of complement activation (GO:0030449) | 5.22234298 |
| 25 | positive regulation of respiratory burst (GO:0060267) | 5.20544881 |
| 26 | protein activation cascade (GO:0072376) | 5.20016874 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 5.13126245 |
| 28 | positive regulation of glycoprotein metabolic process (GO:1903020) | 5.04696990 |
| 29 | regulation of Cdc42 GTPase activity (GO:0043088) | 4.98688556 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.96914115 |
| 31 | regulation of T-helper 1 type immune response (GO:0002825) | 4.93436848 |
| 32 | positive regulation of interleukin-1 secretion (GO:0050716) | 4.92004844 |
| 33 | dendritic cell chemotaxis (GO:0002407) | 4.91666331 |
| 34 | superoxide anion generation (GO:0042554) | 4.89770155 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.87298891 |
| 36 | regulation of fibrinolysis (GO:0051917) | 4.83038651 |
| 37 | drug catabolic process (GO:0042737) | 4.82947150 |
| 38 | cellular glucuronidation (GO:0052695) | 4.81316615 |
| 39 | hydrogen peroxide catabolic process (GO:0042744) | 4.77608361 |
| 40 | urea metabolic process (GO:0019627) | 4.75041460 |
| 41 | uronic acid metabolic process (GO:0006063) | 4.71768685 |
| 42 | glucuronate metabolic process (GO:0019585) | 4.71768685 |
| 43 | exogenous drug catabolic process (GO:0042738) | 4.70309944 |
| 44 | regulation of interleukin-1 beta secretion (GO:0050706) | 4.66164227 |
| 45 | epoxygenase P450 pathway (GO:0019373) | 4.65201078 |
| 46 | regulation of granulocyte chemotaxis (GO:0071622) | 4.62278815 |
| 47 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.56136921 |
| 48 | regulation of neutrophil chemotaxis (GO:0090022) | 4.48264486 |
| 49 | regulation of neutrophil migration (GO:1902622) | 4.48264486 |
| 50 | ethanol oxidation (GO:0006069) | 4.45464445 |
| 51 | regulation of T-helper cell differentiation (GO:0045622) | 4.43870161 |
| 52 | urea cycle (GO:0000050) | 4.41080930 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 4.38592647 |
| 54 | neurotransmitter catabolic process (GO:0042135) | 4.35269697 |
| 55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.35011041 |
| 56 | phospholipid efflux (GO:0033700) | 4.31492513 |
| 57 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.29812001 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.29394125 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.29394125 |
| 60 | regulation of interleukin-1 secretion (GO:0050704) | 4.27561710 |
| 61 | response to prostaglandin (GO:0034694) | 4.27382031 |
| 62 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 4.23005604 |
| 63 | regulation of receptor biosynthetic process (GO:0010869) | 4.22136953 |
| 64 | positive regulation of interleukin-1 production (GO:0032732) | 4.22038515 |
| 65 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.21414351 |
| 66 | fibrinolysis (GO:0042730) | 4.19933601 |
| 67 | positive regulation of interleukin-1 beta production (GO:0032731) | 4.19476857 |
| 68 | amine biosynthetic process (GO:0009309) | 4.18408398 |
| 69 | cellular biogenic amine biosynthetic process (GO:0042401) | 4.18408398 |
| 70 | regulation of cholesterol esterification (GO:0010872) | 4.14817761 |
| 71 | acute-phase response (GO:0006953) | 4.14104362 |
| 72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.13146285 |
| 73 | low-density lipoprotein particle remodeling (GO:0034374) | 4.08700624 |
| 74 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 4.06990446 |
| 75 | regulation of apoptotic cell clearance (GO:2000425) | 4.05943758 |
| 76 | protein-lipid complex remodeling (GO:0034368) | 3.96988430 |
| 77 | macromolecular complex remodeling (GO:0034367) | 3.96988430 |
| 78 | plasma lipoprotein particle remodeling (GO:0034369) | 3.96988430 |
| 79 | eosinophil migration (GO:0072677) | 3.95195960 |
| 80 | biotin metabolic process (GO:0006768) | 3.91103119 |
| 81 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.88836783 |
| 82 | renal absorption (GO:0070293) | 3.87061451 |
| 83 | intestinal absorption (GO:0050892) | 3.86558957 |
| 84 | protein carboxylation (GO:0018214) | 3.86305947 |
| 85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.86305947 |
| 86 | angiotensin maturation (GO:0002003) | 3.85091745 |
| 87 | drug metabolic process (GO:0017144) | 3.83808206 |
| 88 | regulation of cellular extravasation (GO:0002691) | 3.83283687 |
| 89 | leukotriene biosynthetic process (GO:0019370) | 3.82141489 |
| 90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.79110522 |
| 91 | L-phenylalanine catabolic process (GO:0006559) | 3.79110522 |
| 92 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.77339177 |
| 93 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.73644950 |
| 94 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.73141651 |
| 95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.69438093 |
| 96 | L-phenylalanine metabolic process (GO:0006558) | 3.69438093 |
| 97 | tongue development (GO:0043586) | 3.68076893 |
| 98 | positive regulation of interleukin-12 production (GO:0032735) | 3.67389136 |
| 99 | regulation of humoral immune response (GO:0002920) | 3.66243548 |
| 100 | plasma lipoprotein particle assembly (GO:0034377) | 3.65371485 |
| 101 | glyoxylate metabolic process (GO:0046487) | 3.65104951 |
| 102 | bile acid metabolic process (GO:0008206) | 3.63654728 |
| 103 | negative regulation of blood coagulation (GO:0030195) | 3.61025677 |
| 104 | negative regulation of hemostasis (GO:1900047) | 3.61025677 |
| 105 | hormone catabolic process (GO:0042447) | 3.59237120 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58136824 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58136824 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.55973086 |
| 109 | dendritic cell migration (GO:0036336) | 3.54111480 |
| 110 | ethanol metabolic process (GO:0006067) | 3.53223135 |
| 111 | blood coagulation, intrinsic pathway (GO:0007597) | 3.52726770 |
| 112 | bile acid and bile salt transport (GO:0015721) | 3.52600565 |
| 113 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51974186 |
| 114 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.50758305 |
| 115 | regulation of respiratory burst (GO:0060263) | 3.50193519 |
| 116 | regulation of triglyceride catabolic process (GO:0010896) | 3.47463350 |
| 117 | negative regulation of coagulation (GO:0050819) | 3.45643829 |
| 118 | aromatic amino acid family catabolic process (GO:0009074) | 3.40592549 |
| 119 | positive regulation of pseudopodium assembly (GO:0031274) | 3.39848802 |
| 120 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.38315463 |
| 121 | phenylpropanoid metabolic process (GO:0009698) | 3.37326585 |
| 122 | pericardium development (GO:0060039) | 3.36953150 |
| 123 | regulation of RIG-I signaling pathway (GO:0039535) | 3.36314395 |
| 124 | lipoprotein metabolic process (GO:0042157) | 3.36275085 |
| 125 | primary alcohol catabolic process (GO:0034310) | 3.34100941 |
| 126 | acute inflammatory response (GO:0002526) | 3.33514331 |
| 127 | arginine metabolic process (GO:0006525) | 3.32890351 |
| 128 | plasma lipoprotein particle organization (GO:0071827) | 3.31060347 |
| 129 | cytokine secretion (GO:0050663) | 3.29968766 |
| 130 | cholesterol efflux (GO:0033344) | 3.29713454 |
| 131 | regulation of activation of Janus kinase activity (GO:0010533) | 3.29634069 |
| 132 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.29356975 |
| 133 | protein-lipid complex assembly (GO:0065005) | 3.29266307 |
| 134 | humoral immune response (GO:0006959) | 3.27784021 |
| 135 | hydrogen peroxide metabolic process (GO:0042743) | 3.27722365 |
| 136 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.26907214 |
| 137 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.26907214 |
| 138 | negative regulation of protein activation cascade (GO:2000258) | 3.25970558 |
| 139 | alkaloid metabolic process (GO:0009820) | 3.24535873 |
| 140 | * dendritic cell differentiation (GO:0097028) | 3.23144462 |
| 141 | antimicrobial humoral response (GO:0019730) | 3.23046450 |
| 142 | antibacterial humoral response (GO:0019731) | 3.22722805 |
| 143 | daunorubicin metabolic process (GO:0044597) | 3.21512921 |
| 144 | polyketide metabolic process (GO:0030638) | 3.21512921 |
| 145 | doxorubicin metabolic process (GO:0044598) | 3.21512921 |
| 146 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.19247245 |
| 147 | negative regulation of wound healing (GO:0061045) | 3.18153323 |
| 148 | leukotriene metabolic process (GO:0006691) | 3.17967503 |
| 149 | lung vasculature development (GO:0060426) | 3.16741952 |
| 150 | cellular response to ATP (GO:0071318) | 3.15770549 |
| 151 | protein-lipid complex subunit organization (GO:0071825) | 3.13446077 |
| 152 | diaphragm development (GO:0060539) | 3.13217519 |
| 153 | intestinal cholesterol absorption (GO:0030299) | 3.12570357 |
| 154 | neutrophil activation (GO:0042119) | 3.08465957 |
| 155 | reverse cholesterol transport (GO:0043691) | 3.07174496 |
| 156 | gas transport (GO:0015669) | 3.06838791 |
| 157 | tryptophan catabolic process (GO:0006569) | 3.06354350 |
| 158 | indole-containing compound catabolic process (GO:0042436) | 3.06354350 |
| 159 | indolalkylamine catabolic process (GO:0046218) | 3.06354350 |
| 160 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.06017424 |
| 161 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.04726085 |
| 162 | embryonic digestive tract development (GO:0048566) | 3.01916300 |
| 163 | synaptic transmission, cholinergic (GO:0007271) | 3.00656104 |
| 164 | positive regulation of transcription factor import into nucleus (GO:0042993) | 3.00131550 |
| 165 | regulation of pseudopodium assembly (GO:0031272) | 2.99958773 |
| 166 | nitric oxide biosynthetic process (GO:0006809) | 2.99675723 |
| 167 | regulation of natural killer cell differentiation (GO:0032823) | 2.96972143 |
| 168 | regulation of cholesterol homeostasis (GO:2000188) | 2.96743766 |
| 169 | bile acid biosynthetic process (GO:0006699) | 2.94253306 |
| 170 | glutathione biosynthetic process (GO:0006750) | 2.93821886 |
| 171 | triglyceride homeostasis (GO:0070328) | 2.93224471 |
| 172 | acylglycerol homeostasis (GO:0055090) | 2.93224471 |
| 173 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.90438197 |
| 174 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.85941597 |
| 175 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.84807011 |
| 176 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.83632717 |
| 177 | skeletal muscle organ development (GO:0060538) | 2.80901774 |
| 178 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.79904961 |
| 179 | positive regulation of leukocyte migration (GO:0002687) | 2.79233437 |
| 180 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.74481228 |
| 181 | positive regulation of glucose import (GO:0046326) | 2.73543316 |
| 182 | vitamin transmembrane transport (GO:0035461) | 2.73334751 |
| 183 | positive regulation of interleukin-4 production (GO:0032753) | 2.71112386 |
| 184 | granulocyte activation (GO:0036230) | 2.70751385 |
| 185 | regulation of interleukin-1 production (GO:0032652) | 2.67306693 |
| 186 | detection of bacterium (GO:0016045) | 2.67067416 |
| 187 | auditory behavior (GO:0031223) | 2.66523099 |
| 188 | superoxide metabolic process (GO:0006801) | 2.65634497 |
| 189 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.64519392 |
| 190 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.64061188 |
| 191 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.63353098 |
| 192 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 12.7805173 |
| 193 | imidazole-containing compound metabolic process (GO:0052803) | 11.7045995 |
| 194 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 10.4120783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.42079124 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.40231960 |
| 3 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.99593714 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.75329570 |
| 5 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.72004655 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.50345030 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25394444 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24927759 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.05259697 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98910028 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.97267696 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87340298 |
| 13 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.85461438 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84196666 |
| 15 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.82677980 |
| 16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78782181 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73092913 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.72698010 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69668211 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65970965 |
| 21 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.65401548 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.63114436 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.62211354 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.61426352 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60955412 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.59405922 |
| 27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.56891625 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55123679 |
| 29 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54151998 |
| 30 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48694137 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45960287 |
| 32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45337862 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44950281 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44505435 |
| 35 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.44371708 |
| 36 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44254780 |
| 37 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.43826103 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43460136 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.42744406 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.42029120 |
| 41 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.39580265 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.39320706 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.39034011 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37748779 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36852798 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36852798 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35386862 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34881017 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34283153 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33816153 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.33534490 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.33534490 |
| 53 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.33441656 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.32575814 |
| 55 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.31901741 |
| 56 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.31061224 |
| 57 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.30099065 |
| 58 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28573257 |
| 59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25770976 |
| 60 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23782908 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21696558 |
| 62 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.21408377 |
| 63 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21269199 |
| 64 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.20193433 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19833604 |
| 66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19207581 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19020537 |
| 68 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.17979508 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17213195 |
| 70 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.15779780 |
| 71 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.15573993 |
| 72 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.14238888 |
| 73 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13985415 |
| 74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13590706 |
| 75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12007309 |
| 76 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.11375274 |
| 77 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10865896 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10205259 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09374558 |
| 80 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08273449 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08228649 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07798617 |
| 83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.07629092 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06311348 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05331090 |
| 86 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04453672 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03834180 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03109146 |
| 89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00912090 |
| 90 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00759207 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98204943 |
| 92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97151233 |
| 93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96787259 |
| 94 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96308689 |
| 95 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96292708 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96237452 |
| 97 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96159372 |
| 98 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95587805 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94857364 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94502951 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94349994 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92744849 |
| 103 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92594266 |
| 104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92158900 |
| 105 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91066270 |
| 106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90941611 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90484813 |
| 108 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90264831 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.89421967 |
| 110 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.88200599 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87912277 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87664607 |
| 113 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86675129 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86181738 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85985741 |
| 116 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.85144660 |
| 117 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85003071 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84682492 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84448654 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84244782 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83118469 |
| 122 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.82851962 |
| 123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82304463 |
| 124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82287204 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82263304 |
| 126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.82056767 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82026922 |
| 128 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81997371 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.81355176 |
| 130 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80766805 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80753180 |
| 132 | SA1_27219007_Chip-Seq_Bcells_Human | 0.80507160 |
| 133 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80386450 |
| 134 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.79775965 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79552215 |
| 136 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.79213682 |
| 137 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.79133074 |
| 138 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.79091344 |
| 139 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78244187 |
| 140 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78242916 |
| 141 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78182251 |
| 142 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.78176813 |
| 143 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.78088228 |
| 144 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.78058826 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76574751 |
| 146 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75640886 |
| 147 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.74330217 |
| 148 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73847061 |
| 149 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71883525 |
| 150 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71814572 |
| 151 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70740404 |
| 152 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.69998265 |
| 153 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.68952889 |
| 154 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.67992214 |
| 155 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67922872 |
| 156 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67756902 |
| 157 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.67384767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 8.68516138 |
| 2 | MP0002876_abnormal_thyroid_physiology | 7.27526289 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 6.83435058 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 6.18251491 |
| 5 | MP0000685_abnormal_immune_system | 5.75061812 |
| 6 | MP0005360_urolithiasis | 5.44863397 |
| 7 | MP0005365_abnormal_bile_salt | 4.35486022 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 4.13660124 |
| 9 | MP0001348_abnormal_lacrimal_gland | 4.09876021 |
| 10 | MP0001346_abnormal_lacrimal_gland | 3.85226635 |
| 11 | MP0001835_abnormal_antigen_presentation | 3.76033401 |
| 12 | MP0001666_abnormal_nutrient_absorption | 3.62301042 |
| 13 | MP0004510_myositis | 3.53757855 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 3.37089303 |
| 15 | MP0009840_abnormal_foam_cell | 3.28210371 |
| 16 | MP0005310_abnormal_salivary_gland | 3.01173463 |
| 17 | MP0003195_calcinosis | 2.93027899 |
| 18 | MP0001873_stomach_inflammation | 2.76086450 |
| 19 | MP0003879_abnormal_hair_cell | 2.67878978 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.56104928 |
| 21 | MP0003252_abnormal_bile_duct | 2.46878406 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.21449464 |
| 23 | MP0005671_abnormal_response_to | 2.19565968 |
| 24 | MP0006082_CNS_inflammation | 2.10085180 |
| 25 | MP0000003_abnormal_adipose_tissue | 2.05832173 |
| 26 | MP0010329_abnormal_lipoprotein_level | 2.04752808 |
| 27 | MP0005451_abnormal_body_composition | 1.81457466 |
| 28 | MP0003959_abnormal_lean_body | 1.81390376 |
| 29 | MP0005647_abnormal_sex_gland | 1.78037907 |
| 30 | MP0001764_abnormal_homeostasis | 1.77014938 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.76752242 |
| 32 | MP0003436_decreased_susceptibility_to | 1.72980511 |
| 33 | MP0005332_abnormal_amino_acid | 1.67135541 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.62397173 |
| 35 | MP0005166_decreased_susceptibility_to | 1.59135014 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.54200700 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.53930651 |
| 38 | MP0001853_heart_inflammation | 1.48629525 |
| 39 | MP0000609_abnormal_liver_physiology | 1.45346636 |
| 40 | MP0000604_amyloidosis | 1.42467194 |
| 41 | MP0003866_abnormal_defecation | 1.39466230 |
| 42 | MP0001790_abnormal_immune_system | 1.38327404 |
| 43 | MP0005387_immune_system_phenotype | 1.38327404 |
| 44 | MP0003303_peritoneal_inflammation | 1.35257562 |
| 45 | MP0004264_abnormal_extraembryonic_tissu | 1.32322744 |
| 46 | MP0002971_abnormal_brown_adipose | 1.28077062 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.19739521 |
| 48 | MP0003638_abnormal_response/metabolism_ | 1.18387823 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.18082814 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.17359851 |
| 51 | MP0000470_abnormal_stomach_morphology | 1.13831652 |
| 52 | MP0009785_altered_susceptibility_to | 1.13590876 |
| 53 | MP0009115_abnormal_fat_cell | 1.12370769 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.09456950 |
| 55 | MP0001851_eye_inflammation | 1.08450701 |
| 56 | MP0001501_abnormal_sleep_pattern | 1.07533740 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.06166473 |
| 58 | MP0002132_abnormal_respiratory_system | 1.05137633 |
| 59 | MP0004858_abnormal_nervous_system | 1.04919280 |
| 60 | MP0004947_skin_inflammation | 1.02220932 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.02013763 |
| 62 | MP0009764_decreased_sensitivity_to | 1.01301140 |
| 63 | MP0001800_abnormal_humoral_immune | 0.98767482 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 0.97503941 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96813819 |
| 66 | MP0005023_abnormal_wound_healing | 0.94581775 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 0.93803177 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.91879591 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.90524792 |
| 70 | MP0000858_altered_metastatic_potential | 0.89776916 |
| 71 | * MP0005025_abnormal_response_to | 0.89216429 |
| 72 | MP0000383_abnormal_hair_follicle | 0.89173019 |
| 73 | MP0005000_abnormal_immune_tolerance | 0.88584314 |
| 74 | MP0002405_respiratory_system_inflammati | 0.86424580 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 0.85116724 |
| 76 | MP0001881_abnormal_mammary_gland | 0.84497199 |
| 77 | MP0002160_abnormal_reproductive_system | 0.84362970 |
| 78 | MP0008874_decreased_physiological_sensi | 0.83545179 |
| 79 | MP0005464_abnormal_platelet_physiology | 0.83094323 |
| 80 | MP0000613_abnormal_salivary_gland | 0.82307816 |
| 81 | MP0003329_amyloid_beta_deposits | 0.82083157 |
| 82 | MP0010155_abnormal_intestine_physiology | 0.82048883 |
| 83 | MP0002733_abnormal_thermal_nociception | 0.81800377 |
| 84 | MP0001542_abnormal_bone_strength | 0.81636462 |
| 85 | MP0009379_abnormal_foot_pigmentation | 0.81586221 |
| 86 | MP0000681_abnormal_thyroid_gland | 0.81255592 |
| 87 | MP0009763_increased_sensitivity_to | 0.81141029 |
| 88 | MP0003868_abnormal_feces_composition | 0.80599411 |
| 89 | MP0003300_gastrointestinal_ulcer | 0.80534451 |
| 90 | MP0000249_abnormal_blood_vessel | 0.80279545 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.80270328 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.79892391 |
| 93 | MP0002970_abnormal_white_adipose | 0.77312912 |
| 94 | MP0000538_abnormal_urinary_bladder | 0.77186532 |
| 95 | MP0010678_abnormal_skin_adnexa | 0.75828318 |
| 96 | MP0005375_adipose_tissue_phenotype | 0.75719399 |
| 97 | MP0002006_tumorigenesis | 0.75652194 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.73881249 |
| 99 | MP0004134_abnormal_chest_morphology | 0.73253621 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.73133924 |
| 101 | MP0005636_abnormal_mineral_homeostasis | 0.72700099 |
| 102 | MP0010386_abnormal_urinary_bladder | 0.71878479 |
| 103 | MP0003183_abnormal_peptide_metabolism | 0.71784777 |
| 104 | MP0006054_spinal_hemorrhage | 0.70315403 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.69627717 |
| 106 | MP0005164_abnormal_response_to | 0.69321854 |
| 107 | MP0005408_hypopigmentation | 0.68999003 |
| 108 | MP0003724_increased_susceptibility_to | 0.68542843 |
| 109 | MP0000579_abnormal_nail_morphology | 0.67178132 |
| 110 | MP0005409_darkened_coat_color | 0.66881448 |
| 111 | MP0008004_abnormal_stomach_pH | 0.66790087 |
| 112 | MP0002419_abnormal_innate_immunity | 0.65165886 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.65093018 |
| 114 | MP0002452_abnormal_antigen_presenting | 0.64269715 |
| 115 | MP0005670_abnormal_white_adipose | 0.64197390 |
| 116 | MP0001664_abnormal_digestion | 0.63830381 |
| 117 | MP0010352_gastrointestinal_tract_polyps | 0.62838077 |
| 118 | MP0002734_abnormal_mechanical_nocicepti | 0.61174128 |
| 119 | MP0000598_abnormal_liver_morphology | 0.60695867 |
| 120 | MP0002723_abnormal_immune_serum | 0.60689508 |
| 121 | MP0005334_abnormal_fat_pad | 0.59855339 |
| 122 | MP0002998_abnormal_bone_remodeling | 0.58559142 |
| 123 | MP0003045_fibrosis | 0.58397790 |
| 124 | MP0000566_synostosis | 0.56684429 |
| 125 | MP0002638_abnormal_pupillary_reflex | 0.55964515 |
| 126 | MP0005448_abnormal_energy_balance | 0.55825156 |
| 127 | MP0002796_impaired_skin_barrier | 0.52398897 |
| 128 | MP0008469_abnormal_protein_level | 0.51010729 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.50254194 |
| 130 | MP0001485_abnormal_pinna_reflex | 0.49087463 |
| 131 | MP0000716_abnormal_immune_system | 0.48857931 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.48318817 |
| 133 | MP0003448_altered_tumor_morphology | 0.47988264 |
| 134 | MP0000427_abnormal_hair_cycle | 0.47340575 |
| 135 | MP0008872_abnormal_physiological_respon | 0.46115648 |
| 136 | * MP0001819_abnormal_immune_cell | 0.46091710 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.45452709 |
| 138 | MP0000467_abnormal_esophagus_morphology | 0.44505241 |
| 139 | * MP0002420_abnormal_adaptive_immunity | 0.44461504 |
| 140 | MP0001970_abnormal_pain_threshold | 0.43503914 |
| 141 | MP0000516_abnormal_urinary_system | 0.43321375 |
| 142 | MP0005367_renal/urinary_system_phenotyp | 0.43321375 |
| 143 | MP0003806_abnormal_nucleotide_metabolis | 0.42667220 |
| 144 | MP0001663_abnormal_digestive_system | 0.42048752 |
| 145 | MP0006138_congestive_heart_failure | 0.38242113 |
| 146 | MP0002909_abnormal_adrenal_gland | 0.37738720 |
| 147 | MP0008569_lethality_at_weaning | 0.37193082 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.36557953 |
| 149 | MP0003075_altered_response_to | 0.36119148 |
| 150 | MP0002166_altered_tumor_susceptibility | 0.35660226 |
| 151 | MP0001756_abnormal_urination | 0.34985428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 8.14246927 |
| 2 | Complement deficiency (HP:0004431) | 7.13857239 |
| 3 | Chronic mucocutaneous candidiasis (HP:0002728) | 6.75693182 |
| 4 | Recurrent cutaneous fungal infections (HP:0011370) | 6.75693182 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.54038383 |
| 6 | Abnormality of complement system (HP:0005339) | 6.35820887 |
| 7 | Glomerulonephritis (HP:0000099) | 6.31323290 |
| 8 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 6.31268999 |
| 9 | Deep venous thrombosis (HP:0002625) | 5.87785787 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.55970272 |
| 11 | Prolonged neonatal jaundice (HP:0006579) | 5.14423791 |
| 12 | Keratoconjunctivitis (HP:0001096) | 5.11838636 |
| 13 | Abnormality of proline metabolism (HP:0010907) | 4.95571007 |
| 14 | Hydroxyprolinuria (HP:0003080) | 4.95571007 |
| 15 | Type I diabetes mellitus (HP:0100651) | 4.90825924 |
| 16 | Malnutrition (HP:0004395) | 4.83152024 |
| 17 | Nephritis (HP:0000123) | 4.61984817 |
| 18 | Upper limb muscle weakness (HP:0003484) | 4.61553664 |
| 19 | Double outlet right ventricle (HP:0001719) | 4.50531305 |
| 20 | Congenital malformation of the right heart (HP:0011723) | 4.50531305 |
| 21 | Increased IgE level (HP:0003212) | 4.44727077 |
| 22 | Right ventricular cardiomyopathy (HP:0011663) | 4.44364434 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 4.41043983 |
| 24 | Eczematoid dermatitis (HP:0000976) | 4.37785306 |
| 25 | Tongue fasciculations (HP:0001308) | 4.26780382 |
| 26 | Asplenia (HP:0001746) | 4.20100585 |
| 27 | Type 2 muscle fiber atrophy (HP:0003554) | 4.15494474 |
| 28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.14061341 |
| 29 | Abnormal pupillary function (HP:0007686) | 4.13237311 |
| 30 | Fat malabsorption (HP:0002630) | 4.07951923 |
| 31 | Muscle fibrillation (HP:0010546) | 4.07448629 |
| 32 | Confusion (HP:0001289) | 4.01727342 |
| 33 | Recurrent skin infections (HP:0001581) | 3.98421156 |
| 34 | Xanthomatosis (HP:0000991) | 3.96214024 |
| 35 | Abnormality of the gastric mucosa (HP:0004295) | 3.95664422 |
| 36 | Joint hemorrhage (HP:0005261) | 3.93458927 |
| 37 | Recurrent fungal infections (HP:0002841) | 3.83024091 |
| 38 | Truncus arteriosus (HP:0001660) | 3.81098488 |
| 39 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.63599125 |
| 40 | Muscle fiber atrophy (HP:0100295) | 3.59104676 |
| 41 | Plantar hyperkeratosis (HP:0007556) | 3.55997186 |
| 42 | Hypercortisolism (HP:0001578) | 3.55453258 |
| 43 | Annular pancreas (HP:0001734) | 3.47005524 |
| 44 | Hemorrhage of the eye (HP:0011885) | 3.43094818 |
| 45 | Steatorrhea (HP:0002570) | 3.42321086 |
| 46 | Fatigable weakness (HP:0003473) | 3.36037149 |
| 47 | Abnormality of the neuromuscular junction (HP:0003398) | 3.36037149 |
| 48 | Conjugated hyperbilirubinemia (HP:0002908) | 3.34835122 |
| 49 | Reticulocytosis (HP:0001923) | 3.29805165 |
| 50 | Abnormality of the aortic arch (HP:0012303) | 3.22681229 |
| 51 | Intrahepatic cholestasis (HP:0001406) | 3.22562000 |
| 52 | Lip pit (HP:0100267) | 3.13319606 |
| 53 | Hypoplasia of the uterus (HP:0000013) | 3.13195230 |
| 54 | Palmoplantar hyperkeratosis (HP:0000972) | 3.10648861 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.08844428 |
| 56 | Onycholysis (HP:0001806) | 3.04748664 |
| 57 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.03266515 |
| 58 | Hypolipoproteinemia (HP:0010981) | 3.00395669 |
| 59 | Purpura (HP:0000979) | 2.97197210 |
| 60 | Bilateral microphthalmos (HP:0007633) | 2.96352841 |
| 61 | Abnormality of the common coagulation pathway (HP:0010990) | 2.94243659 |
| 62 | Hypoplasia of dental enamel (HP:0006297) | 2.93859619 |
| 63 | Palmar hyperkeratosis (HP:0010765) | 2.89725259 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.89527963 |
| 65 | Hyperglycinuria (HP:0003108) | 2.87906454 |
| 66 | Hyperglycemia (HP:0003074) | 2.86556890 |
| 67 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.85190087 |
| 68 | Milia (HP:0001056) | 2.84130163 |
| 69 | Abnormal pancreas size (HP:0012094) | 2.80759659 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.77154951 |
| 71 | Weak cry (HP:0001612) | 2.75806609 |
| 72 | Recurrent pneumonia (HP:0006532) | 2.73759657 |
| 73 | Ileus (HP:0002595) | 2.70773243 |
| 74 | Vascular calcification (HP:0004934) | 2.69557770 |
| 75 | Hyperlipoproteinemia (HP:0010980) | 2.68749961 |
| 76 | Gingival bleeding (HP:0000225) | 2.62389578 |
| 77 | Xerostomia (HP:0000217) | 2.61620408 |
| 78 | Amelogenesis imperfecta (HP:0000705) | 2.59680804 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.59350290 |
| 80 | Poikilocytosis (HP:0004447) | 2.58728488 |
| 81 | Abnormal auditory evoked potentials (HP:0006958) | 2.58603130 |
| 82 | Premature loss of primary teeth (HP:0006323) | 2.55582669 |
| 83 | Cholelithiasis (HP:0001081) | 2.52845721 |
| 84 | Agammaglobulinemia (HP:0004432) | 2.50537370 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.48701624 |
| 86 | Chronic diarrhea (HP:0002028) | 2.48214074 |
| 87 | Recurrent bacterial skin infections (HP:0005406) | 2.47512275 |
| 88 | Spontaneous abortion (HP:0005268) | 2.46564475 |
| 89 | Tetraparesis (HP:0002273) | 2.46145467 |
| 90 | Recurrent lower respiratory tract infections (HP:0002783) | 2.43651336 |
| 91 | Keratitis (HP:0000491) | 2.42150778 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.39922838 |
| 93 | Myositis (HP:0100614) | 2.39849663 |
| 94 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.39496282 |
| 95 | Hyperammonemia (HP:0001987) | 2.38003522 |
| 96 | Seborrheic dermatitis (HP:0001051) | 2.37032963 |
| 97 | Cardiovascular calcification (HP:0011915) | 2.36189947 |
| 98 | Vasculitis (HP:0002633) | 2.34397605 |
| 99 | Mitral stenosis (HP:0001718) | 2.34392012 |
| 100 | Pustule (HP:0200039) | 2.32506156 |
| 101 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.31608920 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 2.31513808 |
| 103 | Transposition of the great arteries (HP:0001669) | 2.30887311 |
| 104 | Abnormal connection of the cardiac segments (HP:0011545) | 2.30887311 |
| 105 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.30887311 |
| 106 | Abnormal gallbladder morphology (HP:0012437) | 2.30490173 |
| 107 | Joint swelling (HP:0001386) | 2.29955685 |
| 108 | Chronic otitis media (HP:0000389) | 2.29935585 |
| 109 | Recurrent bronchitis (HP:0002837) | 2.26379582 |
| 110 | Respiratory distress (HP:0002098) | 2.26189777 |
| 111 | Hepatitis (HP:0012115) | 2.23191415 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 2.21699256 |
| 113 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.19217941 |
| 114 | Rickets (HP:0002748) | 2.16132748 |
| 115 | Urticaria (HP:0001025) | 2.14270310 |
| 116 | Fragile nails (HP:0001808) | 2.13733684 |
| 117 | Pulmonary embolism (HP:0002204) | 2.13575953 |
| 118 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13443513 |
| 119 | Thrombophlebitis (HP:0004418) | 2.13434746 |
| 120 | Squamous cell carcinoma (HP:0002860) | 2.13368226 |
| 121 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.13322087 |
| 122 | Pancreatitis (HP:0001733) | 2.12591210 |
| 123 | Hypophosphatemia (HP:0002148) | 2.12533127 |
| 124 | Ketoacidosis (HP:0001993) | 2.09940244 |
| 125 | Glycosuria (HP:0003076) | 2.09879151 |
| 126 | Abnormality of urine glucose concentration (HP:0011016) | 2.09879151 |
| 127 | Easy fatigability (HP:0003388) | 2.09268898 |
| 128 | Abnormality of placental membranes (HP:0011409) | 2.07046609 |
| 129 | Amniotic constriction ring (HP:0009775) | 2.07046609 |
| 130 | Recurrent abscess formation (HP:0002722) | 2.04837755 |
| 131 | Menorrhagia (HP:0000132) | 2.04683265 |
| 132 | Colitis (HP:0002583) | 2.04184984 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 2.00694597 |
| 134 | Decreased muscle mass (HP:0003199) | 1.99958506 |
| 135 | Ventricular tachycardia (HP:0004756) | 1.99484309 |
| 136 | Nasal polyposis (HP:0100582) | 1.98730123 |
| 137 | Inflammation of the large intestine (HP:0002037) | 1.98217994 |
| 138 | Amyloidosis (HP:0011034) | 1.97501405 |
| 139 | Emphysema (HP:0002097) | 1.95331195 |
| 140 | Skin rash (HP:0000988) | 1.94913574 |
| 141 | Myocardial infarction (HP:0001658) | 1.94477197 |
| 142 | Gingivitis (HP:0000230) | 1.94457628 |
| 143 | Focal segmental glomerulosclerosis (HP:0000097) | 1.93626867 |
| 144 | Generalized aminoaciduria (HP:0002909) | 1.93465993 |
| 145 | Flat acetabular roof (HP:0003180) | 1.93121296 |
| 146 | Mediastinal lymphadenopathy (HP:0100721) | 1.93083770 |
| 147 | Cerebral palsy (HP:0100021) | 1.90668849 |
| 148 | Gangrene (HP:0100758) | 1.90315157 |
| 149 | Hypercholesterolemia (HP:0003124) | 1.89846979 |
| 150 | Abnormality of nail color (HP:0100643) | 1.88924953 |
| 151 | Alkalosis (HP:0001948) | 1.88170861 |
| 152 | Acanthocytosis (HP:0001927) | 1.86397471 |
| 153 | Gout (HP:0001997) | 1.85309434 |
| 154 | Pulmonary infiltrates (HP:0002113) | 1.85184129 |
| 155 | Villous atrophy (HP:0011473) | 1.84910762 |
| 156 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.84910762 |
| 157 | Orchitis (HP:0100796) | 1.83439411 |
| 158 | Fragile skin (HP:0001030) | 1.82313359 |
| 159 | Atrophic scars (HP:0001075) | 1.81175739 |
| 160 | Abnormality of macrophages (HP:0004311) | 1.80712235 |
| 161 | Anophthalmia (HP:0000528) | 1.80455721 |
| 162 | Hypoparathyroidism (HP:0000829) | 1.80428185 |
| 163 | Abnormality of reticulocytes (HP:0004312) | 1.80403852 |
| 164 | Palpitations (HP:0001962) | 1.80049657 |
| 165 | Polygenic inheritance (HP:0010982) | 1.79709274 |
| 166 | Facial shape deformation (HP:0011334) | 1.77944788 |
| 167 | Potter facies (HP:0002009) | 1.77944788 |
| 168 | Epidermoid cyst (HP:0200040) | 1.77078480 |
| 169 | Widely patent fontanelles and sutures (HP:0004492) | 1.74335552 |
| 170 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.73192030 |
| 171 | Abnormality of glycine metabolism (HP:0010895) | 1.73192030 |
| 172 | Hemoptysis (HP:0002105) | 1.73184150 |
| 173 | Glomerulosclerosis (HP:0000096) | 1.73161152 |
| 174 | Abnormality of purine metabolism (HP:0004352) | 1.69718093 |
| 175 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.69700001 |
| 176 | Hepatocellular carcinoma (HP:0001402) | 1.69631993 |
| 177 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.69601288 |
| 178 | Abdominal distention (HP:0003270) | 1.67940685 |
| 179 | Elevated alkaline phosphatase (HP:0003155) | 1.67536168 |
| 180 | Late onset (HP:0003584) | 1.66655778 |
| 181 | Recurrent sinusitis (HP:0011108) | 1.66254421 |
| 182 | Polycythemia (HP:0001901) | 1.64591326 |
| 183 | Nausea (HP:0002018) | 1.62005698 |
| 184 | Periodontitis (HP:0000704) | 1.61546892 |
| 185 | Meningitis (HP:0001287) | 1.61223720 |
| 186 | Mucopolysacchariduria (HP:0008155) | 1.60873603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 6.65868435 |
| 2 | MST1R | 4.45450659 |
| 3 | DYRK1B | 4.23498370 |
| 4 | RIPK1 | 3.59964189 |
| 5 | BMPR2 | 3.49184192 |
| 6 | IRAK4 | 3.47721073 |
| 7 | IRAK3 | 2.95062390 |
| 8 | ERBB3 | 2.77091398 |
| 9 | DYRK3 | 2.72684369 |
| 10 | EPHA3 | 2.64915395 |
| 11 | PTK6 | 2.33175627 |
| 12 | FGFR4 | 2.31978509 |
| 13 | TBK1 | 2.30766308 |
| 14 | IKBKE | 2.11270467 |
| 15 | EPHA2 | 2.11058434 |
| 16 | JAK3 | 2.10128299 |
| 17 | NME1 | 2.02249114 |
| 18 | EPHB1 | 1.99876743 |
| 19 | BCR | 1.88335179 |
| 20 | ACVR1B | 1.87641792 |
| 21 | TYK2 | 1.85287616 |
| 22 | MAP4K1 | 1.80776618 |
| 23 | CHUK | 1.71288431 |
| 24 | NLK | 1.71168065 |
| 25 | ITK | 1.64021079 |
| 26 | CDC42BPA | 1.63759927 |
| 27 | IKBKB | 1.62642531 |
| 28 | MAP3K12 | 1.61616265 |
| 29 | KDR | 1.60369840 |
| 30 | PRPF4B | 1.43647713 |
| 31 | SMG1 | 1.43137496 |
| 32 | STK24 | 1.42678895 |
| 33 | TIE1 | 1.41271694 |
| 34 | MET | 1.38775870 |
| 35 | JAK2 | 1.35088310 |
| 36 | ERN1 | 1.34904443 |
| 37 | TGFBR1 | 1.33886462 |
| 38 | JAK1 | 1.33096842 |
| 39 | MAP3K2 | 1.29180606 |
| 40 | PTK2 | 1.22231680 |
| 41 | BMPR1B | 1.21852067 |
| 42 | TRIB3 | 1.20231120 |
| 43 | FGFR3 | 1.17469918 |
| 44 | ZAP70 | 1.17004758 |
| 45 | MAP3K1 | 1.13518578 |
| 46 | AKT3 | 1.12307321 |
| 47 | EIF2AK2 | 1.12268888 |
| 48 | DAPK2 | 1.11648452 |
| 49 | BLK | 1.10245266 |
| 50 | MAPK11 | 1.04858755 |
| 51 | BTK | 1.04641732 |
| 52 | FRK | 1.04275415 |
| 53 | PDK2 | 1.03538482 |
| 54 | PIK3CA | 1.03173028 |
| 55 | NUAK1 | 1.02345996 |
| 56 | IRAK1 | 1.01123401 |
| 57 | TSSK6 | 0.97100040 |
| 58 | MST4 | 0.96621147 |
| 59 | SYK | 0.95730618 |
| 60 | TEC | 0.95719137 |
| 61 | PRKAA2 | 0.93064256 |
| 62 | RIPK4 | 0.89568660 |
| 63 | MAP3K3 | 0.87055329 |
| 64 | MAP3K13 | 0.85752960 |
| 65 | MAP3K10 | 0.83223805 |
| 66 | SCYL2 | 0.82735525 |
| 67 | NTRK1 | 0.82645520 |
| 68 | EPHB2 | 0.82206321 |
| 69 | PRKCQ | 0.81298862 |
| 70 | GRK5 | 0.80863734 |
| 71 | MKNK1 | 0.79693199 |
| 72 | MAPKAPK5 | 0.79150222 |
| 73 | FER | 0.78205862 |
| 74 | PKN1 | 0.73228180 |
| 75 | PDPK1 | 0.72441583 |
| 76 | PRKCD | 0.71049470 |
| 77 | CSF1R | 0.70951616 |
| 78 | ICK | 0.70602396 |
| 79 | PRKCI | 0.69890237 |
| 80 | CSK | 0.69712584 |
| 81 | KIT | 0.68724636 |
| 82 | TESK2 | 0.68507288 |
| 83 | MAPKAPK3 | 0.67975947 |
| 84 | SIK3 | 0.65916057 |
| 85 | CDK8 | 0.62931965 |
| 86 | HIPK2 | 0.62721369 |
| 87 | PIM2 | 0.62483258 |
| 88 | RET | 0.61334060 |
| 89 | PIK3CG | 0.59830389 |
| 90 | STK10 | 0.58341930 |
| 91 | MELK | 0.56467360 |
| 92 | PRKACG | 0.56323196 |
| 93 | MAPK15 | 0.55002371 |
| 94 | LYN | 0.53951562 |
| 95 | STK39 | 0.52857949 |
| 96 | OXSR1 | 0.50909743 |
| 97 | MATK | 0.50439397 |
| 98 | LMTK2 | 0.49923490 |
| 99 | MAPK7 | 0.49864783 |
| 100 | GRK6 | 0.49837489 |
| 101 | SIK1 | 0.48618648 |
| 102 | DYRK1A | 0.47274685 |
| 103 | HCK | 0.47072805 |
| 104 | CDK3 | 0.46912474 |
| 105 | PDK1 | 0.45713869 |
| 106 | SRC | 0.45593858 |
| 107 | LCK | 0.44787858 |
| 108 | PLK2 | 0.42626361 |
| 109 | EGFR | 0.42250978 |
| 110 | LRRK2 | 0.42011694 |
| 111 | TGFBR2 | 0.41598900 |
| 112 | DDR2 | 0.41212887 |
| 113 | IGF1R | 0.40515239 |
| 114 | PKN2 | 0.40305661 |
| 115 | FGR | 0.39208270 |
| 116 | DMPK | 0.38872102 |
| 117 | MAP2K2 | 0.38290135 |
| 118 | PRKCE | 0.38002781 |
| 119 | MAP3K7 | 0.37811368 |
| 120 | MAP3K11 | 0.37235639 |
| 121 | RPS6KB2 | 0.36539201 |
| 122 | GRK1 | 0.33928164 |
| 123 | PRKDC | 0.32770149 |
| 124 | FYN | 0.32581328 |
| 125 | ERBB4 | 0.31954967 |
| 126 | INSR | 0.31948924 |
| 127 | NEK9 | 0.31512458 |
| 128 | TXK | 0.30775866 |
| 129 | CDK6 | 0.29778736 |
| 130 | MAPKAPK2 | 0.29271623 |
| 131 | MAP3K6 | 0.29064378 |
| 132 | ERBB2 | 0.28918564 |
| 133 | PRKCZ | 0.28820800 |
| 134 | LATS1 | 0.28515390 |
| 135 | MYLK | 0.25813531 |
| 136 | ROCK2 | 0.23190568 |
| 137 | GRK7 | 0.23017572 |
| 138 | TESK1 | 0.22988759 |
| 139 | DAPK1 | 0.22392339 |
| 140 | PRKG2 | 0.21454302 |
| 141 | PDGFRA | 0.20590185 |
| 142 | ADRBK1 | 0.18669714 |
| 143 | INSRR | 0.18473007 |
| 144 | MAPK8 | 0.18096627 |
| 145 | ADRBK2 | 0.17868358 |
| 146 | PRKCA | 0.17029216 |
| 147 | BRSK1 | 0.15666817 |
| 148 | RPS6KA5 | 0.15276581 |
| 149 | ZAK | 0.14831283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 6.17145133 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.46415391 |
| 3 | Histidine metabolism_Homo sapiens_hsa00340 | 4.17744258 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.44460642 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.25438631 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.12332812 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.02077978 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.88626837 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.75936319 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.56407187 |
| 11 | Retinol metabolism_Homo sapiens_hsa00830 | 2.53019288 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.51077545 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.39799140 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.31608090 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.29590814 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.25456331 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.18103333 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.12347384 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87333280 |
| 20 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.86778908 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.86488780 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.81652336 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79555168 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74577526 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64383862 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.60779294 |
| 27 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.58870922 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58053645 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.57424004 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55798446 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55061421 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48991471 |
| 33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.46939662 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45301229 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.43838862 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41156717 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38677593 |
| 38 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.34290877 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.31676196 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.29969118 |
| 41 | Melanoma_Homo sapiens_hsa05218 | 1.24116629 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.22059248 |
| 43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.18192532 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16882525 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14927019 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.14440823 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13847767 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06428606 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05565795 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03548075 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02799408 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01713936 |
| 53 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98449012 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95926728 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95685536 |
| 56 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.92898840 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.92448535 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.89985774 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88655826 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87890300 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84730833 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83690715 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 0.81953000 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.81926881 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.81893973 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81348345 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81318449 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.81202056 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81177028 |
| 70 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80778685 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.79266392 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72374772 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69986156 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.69133335 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67695092 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.66255941 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65747283 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65068470 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64714960 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64580967 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61794561 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.61524794 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60671564 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.59688830 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.58461248 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57698294 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57560393 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55932315 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52739645 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52607131 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51776734 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50977638 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49469761 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47851346 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46989490 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46776404 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46376797 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46265825 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46094997 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45266894 |
| 101 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45171725 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44853530 |
| 103 | Influenza A_Homo sapiens_hsa05164 | 0.44216710 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44041318 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44005089 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43075031 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42939519 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42835873 |
| 109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40401109 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.39687604 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39377571 |
| 112 | Salivary secretion_Homo sapiens_hsa04970 | 0.38786556 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36961643 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36311992 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35869422 |
| 116 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35798039 |
| 117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.34926783 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34326482 |
| 119 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33245563 |
| 120 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32884329 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32701677 |
| 122 | Adherens junction_Homo sapiens_hsa04520 | 0.32644273 |
| 123 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32332117 |
| 124 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29298431 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28806219 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28391572 |
| 127 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28359959 |
| 128 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26061406 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25922954 |
| 130 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.25252923 |
| 131 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.24501987 |
| 132 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.24172461 |
| 133 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23521232 |
| 134 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22747434 |
| 135 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21337342 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20882279 |
| 137 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.19634297 |
| 138 | Lysosome_Homo sapiens_hsa04142 | 0.19506287 |
| 139 | Olfactory transduction_Homo sapiens_hsa04740 | 0.18848537 |
| 140 | Proteasome_Homo sapiens_hsa03050 | 0.15918839 |
| 141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.15084562 |
| 142 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14720579 |
| 143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13866436 |
| 144 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.13654930 |
| 145 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.13587963 |
| 146 | Viral myocarditis_Homo sapiens_hsa05416 | 0.12584855 |
| 147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.12275026 |
| 148 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.11763714 |

